PROLASTIN-C (alpha-1-proteinase inhibitor)
ALPHA-PROTEINASE INHIBITORS · PULMONARY EMPHYSEMA ASSOCIATED WITH ALPHA-1-PROTEINASE INHIBITOR DEFICIENCY
TALECRIS BIOTHE
Drug class
Alpha-Proteinase Inhibitors
Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy. Read more about Alpha-Proteinase Inhibitors
11 drugs in this class 5 manufacturers
Drugs in Alpha-Proteinase Inhibitors
GLASSIA (alpha-1-proteinase inhibitor)
ALPHA-PROTEINASE INHIBITORS · PULMONARY EMPHYSEMA ASSOCIATED WITH ALPHA-1-PROTEINASE INHIBITOR DEFICIENCY
Takeda Pharmaceuticals America
Filter & compare in the drug finder →
Opens the drug finder with Alpha-Proteinase Inhibitors preselected. Add indication or manufacturer filters there.
Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy.
Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin.
Consequently, this therapeutic class is indicated specifically for adults with congenital alpha-1 antitrypsin deficiency who exhibit clinically evident panacinar emphysema, helping to slow the acceleration of lung tissue destruction.
-
fda.gov
Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy
-
fda.gov
Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin Consequently, this therapeuti...
-
medlineplus.gov
Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin
-
fda.gov
Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin
-
fda.gov
Consequently, this therapeutic class is indicated specifically for adults with congenital alpha-1 antitrypsin deficiency who exhibit clinically evident panacinar emphysema, helping to slow the acceleration of lung tissue destruction
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.